Log In
BCIQ
Print this Print this
 

AVR-RD-01 (formerly AVR-02)

  Manage Alerts
Collapse Summary General Information
Company Avrobio Inc.
DescriptionAutologous CD34+ hematopoietic stem cells modified to express alpha galactosidase A
Molecular Target Alpha galactosidase A
Mechanism of Action 
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation
PartnerUniversity Health Network

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/18/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today